GlassScriptPhysician profile
Gary Allen Vickers
NPI 1902867633
$2,823.90
in general payments reported to CMS, 2019-2025
24 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.21 · 2021: $1,584 · 2022: $692 · 2023: $263 · 2024: $61.40 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.68 | 2021-2025 | Vraylar, Ubrelvy, Synthroid |
| Novo Nordisk INC | $341.42 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $252.00 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $184.98 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $176.85 | 2021-2022 | |
| Abbott Laboratories | $166.50 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $154.29 | 2020-2025 | Repatha, Otezla, Repatha |
| Biohaven Pharmaceuticals, INC. | $141.76 | 2021 | |
| Merck Sharp & Dohme LLC | $102.17 | 2021 | |
| Pfizer INC. | $83.31 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $71.03 | 2021 | |
| Amarin Pharma, INC. | $70.93 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $66.58 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $49.08 | 2020-2021 | |
| Eisai INC. | $45.44 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $31.41 | 2021-2023 | |
| Dexcom, INC. | $18.86 | 2021 | |
| Neurocrine Biosciences, INC. | $17.02 | 2022 | |
| Exact Sciences Corporation | $16.41 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $16.03 | 2021 | |
| Glaxosmithkline, LLC. | $14.13 | 2022 | |
| Allergan, INC. | $12.91 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Vickers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.